The company, whose FDA-approved products include the myeloma drug Darzalex and the chronic leukemia drug Arzerra, hopes to launch its own proprietary product by 2025.
We can taste this one it's so perfect.
Giving a thinly-veiled anonymous interview on a contraband cellphone to brag about how he is illegally running a pharma business from prison reminds us why we miss this guy.
This even applies to pharma apparently.
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
Valeant really Herbalife'd old Billy.
How do you put a price on failure?
Fun with pharma stocks and irony!
Heather Bresch seems to have known that Heather Bresch's management was going to have an adverse effect on Mylan stock.
That brings Martin's grand total to eight...so far.
We hope Bill Ackman is meditating today.
If you're going to talk sh!t about Valeant, just assume that Bill is listening.
Looks like Martin is going to need to find a dope rhyme for "Securities fraud."
Pfizer investors are getting high on their own supply.
Jack Lew: Killer of dreams
Just inject some Botox and turn your worry lines into money lines!